ATE420972T1 - Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivaten - Google Patents
Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivatenInfo
- Publication number
- ATE420972T1 ATE420972T1 AT03778180T AT03778180T ATE420972T1 AT E420972 T1 ATE420972 T1 AT E420972T1 AT 03778180 T AT03778180 T AT 03778180T AT 03778180 T AT03778180 T AT 03778180T AT E420972 T1 ATE420972 T1 AT E420972T1
- Authority
- AT
- Austria
- Prior art keywords
- formula
- lipase
- compound
- nucleoside analogue
- dioxolane derivatives
- Prior art date
Links
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical class C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 title 1
- 229940127073 nucleoside analogue Drugs 0.000 title 1
- 230000000707 stereoselective effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 6
- 108090001060 Lipase Proteins 0.000 abstract 3
- 102000004882 Lipase Human genes 0.000 abstract 3
- 239000004367 Lipase Substances 0.000 abstract 3
- 229940040461 lipase Drugs 0.000 abstract 3
- 235000019421 lipase Nutrition 0.000 abstract 3
- 108090000790 Enzymes Proteins 0.000 abstract 2
- 102000004190 Enzymes Human genes 0.000 abstract 2
- 241001661345 Moesziomyces antarcticus Species 0.000 abstract 2
- 230000002255 enzymatic effect Effects 0.000 abstract 2
- 229940088598 enzyme Drugs 0.000 abstract 2
- 241000222120 Candida <Saccharomycetales> Species 0.000 abstract 1
- 108090000371 Esterases Proteins 0.000 abstract 1
- 102000019280 Pancreatic lipases Human genes 0.000 abstract 1
- 108050006759 Pancreatic lipases Proteins 0.000 abstract 1
- 101000968489 Rhizomucor miehei Lipase Proteins 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 229940116369 pancreatic lipase Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/16—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing two or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
- C12P17/188—Heterocyclic compound containing in the condensed system at least one hetero ring having nitrogen atoms and oxygen atoms as the only ring heteroatoms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US42682102P | 2002-11-18 | 2002-11-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420972T1 true ATE420972T1 (de) | 2009-01-15 |
Family
ID=32393318
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03778180T ATE420972T1 (de) | 2002-11-18 | 2003-11-18 | Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivaten |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7955835B2 (de) |
| EP (1) | EP1573019B1 (de) |
| JP (1) | JP4501135B2 (de) |
| AT (1) | ATE420972T1 (de) |
| AU (1) | AU2003285230B2 (de) |
| CA (1) | CA2505552C (de) |
| DE (1) | DE60325894D1 (de) |
| ES (1) | ES2318179T3 (de) |
| WO (1) | WO2004048590A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE548366T1 (de) * | 2002-01-25 | 2012-03-15 | Shire Biochem Inc | Verfahren zur herstellung von dioxolan nukleosidanalogavorstufen |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL100965A (en) * | 1991-02-22 | 1999-12-31 | Univ Emory | 2-Hydroxymethyl-5-(5-fluorocytosin-l-yl)-1,3-oxathiolane its resolution and pharmaceutical compositions containing it |
| EA004767B1 (ru) | 1998-12-23 | 2004-08-26 | Шайре Байокем Инк. | Аналоги нуклеозида (варианты) и их применение, комбинация и способ лечения вирусных инфекций, фармацевтическая композиция |
| WO2000047759A1 (en) | 1999-02-11 | 2000-08-17 | Shire Biochem Inc. | Stereoselective synthesis of nucleoside analogues |
-
2003
- 2003-11-18 ES ES03778180T patent/ES2318179T3/es not_active Expired - Lifetime
- 2003-11-18 AT AT03778180T patent/ATE420972T1/de not_active IP Right Cessation
- 2003-11-18 DE DE60325894T patent/DE60325894D1/de not_active Expired - Lifetime
- 2003-11-18 JP JP2004554100A patent/JP4501135B2/ja not_active Expired - Lifetime
- 2003-11-18 AU AU2003285230A patent/AU2003285230B2/en not_active Expired
- 2003-11-18 EP EP03778180A patent/EP1573019B1/de not_active Expired - Lifetime
- 2003-11-18 CA CA2505552A patent/CA2505552C/en not_active Expired - Lifetime
- 2003-11-18 WO PCT/CA2003/001798 patent/WO2004048590A1/en not_active Ceased
- 2003-11-18 US US10/535,235 patent/US7955835B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004048590A1 (en) | 2004-06-10 |
| CA2505552A1 (en) | 2004-06-10 |
| EP1573019B1 (de) | 2009-01-14 |
| US7955835B2 (en) | 2011-06-07 |
| AU2003285230A1 (en) | 2004-06-18 |
| JP4501135B2 (ja) | 2010-07-14 |
| DE60325894D1 (de) | 2009-03-05 |
| ES2318179T3 (es) | 2009-05-01 |
| EP1573019A1 (de) | 2005-09-14 |
| AU2003285230B2 (en) | 2010-04-22 |
| CA2505552C (en) | 2012-06-05 |
| JP2006506096A (ja) | 2006-02-23 |
| US20060134763A1 (en) | 2006-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE493502T1 (de) | Glucosamin und verfahren zur herstellung von glucosamin aus mikrobieller biomasse | |
| DE60030988D1 (de) | Verfahren zur Herstellung Von L-Aminosäuren durch Erhöhung des zellulären NADPH | |
| DE69939901D1 (de) | Verfahren und materialien zur herstellung von glucosamin | |
| DK0629701T3 (da) | Enzymatisk hydrolysemetode til fremstilling af C-10 og C-13 hydroxylbærende taxaner, enzymatisk esterificeringsmetode til f | |
| DE60322708D1 (de) | Glucosesensor unter verwendung von glucosedehydrogenase | |
| KR100897457B1 (ko) | 탁수스종의세포배양에의한탁산의생산증진방법 | |
| ATE296357T1 (de) | Verfahren zur herstellung von hochreinen hmg-coa reductase inhibitoren | |
| Jacobsen et al. | Enantioselective enzymatic preparation of chiral glutaric monocarboxylic acids and amides | |
| ATE386134T1 (de) | Verfahren zur herstellung von glutathion | |
| NZ508404A (en) | Alcoholic fermentation using a mineral-enriched yeast as a nutrient source | |
| ATE420972T1 (de) | Stereoselektiver prozess zur herstellung von nukleosidanalogen dioxolan-derivaten | |
| ATE170924T1 (de) | Verfahren zur veresterung von carbonsäuren mit tertiären alkoholen | |
| JP2769194B2 (ja) | 酵素分解方法 | |
| TW200619387A (en) | Lipase powder composition and method for producing esterified product using the same | |
| EE05498B1 (et) | Butnool-I-esteraas | |
| TW200621989A (en) | A method for the preparation of mycophenolate mofetil by enzymatic transesterification | |
| CA2354382C (en) | Process for preparing optically active 1-amino-4-(hydroxymethyl) cyclopent-2-ene derivatives | |
| WO2004041858A3 (en) | Improving growth characteristics of filamentous microorganisms | |
| TW200639257A (en) | Enzymatic synthesis method for a triglyceride of a phenylfatty acid | |
| Matsumoto et al. | How can a yeast catalyze enantioselective protonation? | |
| WO2004081220A3 (en) | A process for enzymatically resolving an enantiomeric mixture of alpha-hydroxy acids | |
| ATE386132T1 (de) | Verfahren zur enantioselektiven öffnung von 3- substituierten oxetan-2-onen unter verwendung der lipasen von candida antarctica oder von burkholderia plantarii | |
| ATE422552T1 (de) | Verfahren zur enzymatischen reduktion von nad und nadp | |
| Secundo et al. | Enzymatic resolution of 3-butene-1, 2-diol in organic solvents and optimization of reaction conditions | |
| Woroniecki et al. | A highly regioselective esterase from Penicillium frequentans IMI 92265 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |